Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.236
Delayed Data
As of Jul 31
 +0.003 / +1.29%
Today’s Change
0.17
Today|||52-Week Range
0.40
+4.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.2M1.3M1.4M1.2M
 
 
 
 
 
Cost of Goods Sold713.0K681.7K699.7K903.7K
 
 
 
 
 
Depreciation And Amortization209.4K276.8K213.0K--
 
 
 
 
 
Operating ExpensesGross Income239.3K297.9K450.3K330.5K
 
 
 
 
 
General Expenses4.7M4.4M3.0M5.9M
 
 
 
 
 
Research And Development4.0M3.6M2.3M4.8M
 
 
 
 
 
Total Operating Expenses5.6M5.3M3.9M6.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-4.1M-2.6M-5.5M
 
 
 
 
 
Extraordinary Credit--25.5M23.6M--
 
 
 
Extraordinary Charge-1.6M-----3.5M
 
 
 
Interest Expense On Debt78.2K70.1K66.2K72.8K
 
 
 
 
 
Other Expenses1.7M0.000.007.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.4M21.4M21.0M-9.1M
 
 
 
 
 
Income Taxes-3.2K0.000.000.00
 
 
Net Income-4.4M21.4M21.0M-9.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS565.2M577.7M601.1M631.1M
 
 
 
 
 
Shares To Calculate EPS Diluted733.9M739.9M770.6M631.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01-$0.01$0.00-$0.01
 
 
 
 
EPS Diluted-$0.01-$0.01-$0.00-$0.01